This is a program of the U.S. Department of Health and Human Services, Office of Public Health Emergency Medical Countermeasures, and the National Institutes of Health. The program is coordinated by NIAID, with the involvement of the National Cancer Institute.
RFP-15-100-SOL-00004. BARDA Chem and RadNuc Animal Model Development – Presolicitation Notice. Posted December 5, 2014. Full solicitation expected on or about January 20, 2015.
PA-15-065: Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR)(R43/R44). First submission date March 6, 2015
Available upon request: PowerPoint presentation on Grant Writing for Success given at the 60th Radiation Research SIT session on September 20, 2014 by Priti Mehrotra, Ph.D. Chief, Immunology Review Branch, Scientific Review Program, Division of Extramural Activities, NIAID, NIH. If interested in obtaining a PDF copy of the presentation, contact Francesca Macchiarini at firstname.lastname@example.org.
FDABAA-14-00120: Food and Drug Administration Broad Agency Announcement for the Advanced Research and Development of Regulatory Science. Rolling receipt date, until February, 2015.
PA-15-034: Administrative Supplements for Research on Sex/Gender Differences (Admin Supp). Application due date – January 12, 2015.
FDA draft guidance (2014), Product Development Under the Animal Rule (PDF)
All Radiological and Nuclear Threats News Releases
News From NIAID-Supported Institutions
Last Updated December 16, 2014